Skip to content

To study efficacy of Simhasyadi kwatha in management of Hyperuricemia.

A clinical study of the effect of Simhasyadi kwatha in the management of Hyperuricemia. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/077754
Enrollment
60
Registered
2024-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Dr Aditi Acharya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of both the sex and age between 20-70 years.2.Naive patients or newly diagnosed patients of Hyperuricemia.3.Patients having serum uric acid more than 6.9mg/dl.4. Patients of Hyperuricemia with Gouty Arthritis.5.Patient recently diagnosed with uncomplicated Hyperuricemia & Gouty Arthritis.6.Hyperuricemic patients suffering from controlled hypertension, diabetes mellitus, CKD upto stage 3.

Exclusion criteria

Exclusion criteria: 1.Asymptomatic patient with Hyperuricemia. 2.Patients suffering from the complications of Hyperuricemia & Gouty Arthritis. 3.Pregnant and lactating women. 4.Presence of disease like CA, HIV, malignant hypertension, uncontrolled diabetes. 5. Patients suffering from major systemic illness or under long term drug treatment. 6.History of hypersensitivity to any of the trial drugs or their ingredients.

Design outcomes

Primary

MeasureTime frame
To asses the effectiveness of SIMHASYADI KWATHA in management of symptomatology of Hyperuricemia.Timepoint: 45 days

Secondary

MeasureTime frame
To compare the effect of SIMHASYADI KWATHA and FEBUXOSTAT on serum uric acid level parameter.Timepoint: 30, 45 and 60 days

Countries

India

Contacts

Public ContactDr Manir Uddin Dewan

Govt Ayurvedic College and Hospital Guwahati

drpjbaishya1967@gmail.com8638019124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026